December 21, 2024 - 00:57

Mortgage rates have seen a notable increase, climbing to 6.72% this week, as reported by recent data. Real estate expert Sam DeBianchi Laviola has shared insights on the implications of these changes for the housing market. According to Laviola, studies indicate that mortgage rates may fluctuate between 6% and 7%, largely influenced by the Federal Reserve's cautious approach to interest rates. Despite the current rise, she predicts that rates could potentially drop to the 5-6% range within the next year.
Laviola emphasizes that the market is currently balanced and healthy, although many homebuyers and sellers may not perceive it that way due to limited inventory. She suggests that now is an opportune time for potential buyers to enter the market, as sellers are generally more willing to negotiate.
For those contemplating a home purchase, Laviola advises securing mortgage pre-approval, being ready to negotiate with sellers, and exploring various lending options beyond the traditional 30-year fixed mortgage to find the best fit for their financial situation.
September 25, 2026 - 03:52
Campaign Finance Complaint Against Let's Go Washington DismissedA campaign finance complaint filed against the political action committee Let`s Go Washington has been dismissed after investigators found no evidence of unreported contributions tied to media...
September 24, 2026 - 22:27
Capital One Financial Corporation to Webcast Conference Call on Third Quarter 2026 EarningsMCLEAN, Va., September 24, 2026 -- Capital One Financial Corporation will report its third quarter 2026 financial results on Tuesday, October 20, 2026. The earnings release is scheduled for...
September 24, 2026 - 04:32
Federal Student Aid Forms for 2027-2028 Released Ahead of ScheduleThe U.S. Department of Education announced Wednesday that the Free Application for Federal Student Aid forms for the 2027-2028 academic year are now available. The release marks an earlier timeline...
September 23, 2026 - 09:02
VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users?Viking Therapeutics has seen its stock outperform major competitors Eli Lilly and Novo Nordisk this month after releasing promising data on its experimental obesity treatment. The results have...